EN
HI
Summary
As of 26 Aug, 2026, Genomic Valley Biotech stock price is ₹31.8. During the trading session, the stock has moved between an intraday low of ₹30.50 and an intraday high of ₹31.85. Over the last 52 weeks, Genomic Valley Biotech has traded between ₹20.10 and ₹46.46.
The stock has recorded a trading volume of 380 shares, with a market capitalization of ₹3054500. Its Average Traded Price (ATP) is ₹30.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹31.80.
Genomic Valley Biotech has an upper circuit limit of ₹31.92 and a lower circuit limit of ₹28.88. The total value traded stands at ₹11764.80, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1. Genomic Valley Biotech also offers a dividend yield of 0%.
Genomic Valley Biotech share price chart
Genomic Valley Biotech Share Key Metrics
Volume
380.00
Market Cap
9.71 CR
LTQ@LTP
3@31.80
ATP
30.96
Var Margin
100 %
Circuit Range
28.88-31.92
Delivery %
- %
Value
11764.80
ASM/GSM
No
Market Lot
1
Genomic Valley Biotech Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
30.24
Sector P/B
1.24
Sec. Div. Yield
0.2
Genomic Valley Biotech Resistance and Support
Pivot 30.75
Resistance
First Resistance
31.1
Second Resistance
31.79
Third Resistance
32.14
Support
First Support
30.06
Second Support
29.71
Third Support
29.02
Genomic Valley Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 31.85 | 31.8 | 4.64% | 31.85 | 30.5 |
| Fri Aug 21 2026 | 30.39 | 30.39 | -0.30% | 31.44 | 30.39 |
| Thu Aug 20 2026 | 29.51 | 30.48 | 3.29% | 30.48 | 28.1 |
Genomic Valley Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-01-15 | Quarterly Results |
| 2025-10-15 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-12-06 | Others |
| 2024-10-07 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Genomic Valley Biotech News
Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Of The Company For The Quarter Ended On June 30, 2026
Genomic Valley Biotech's Board of Directors is scheduled to convene on August 14, 2026, to review and approve the unaudited financial results for the quarter ended June 30, 2026. This meeting will address the company's financial performance.
Aug 06 2026 12:56:17
Genomic Valley Biotech Management
| Name | Position |
|---|---|
| Yogesh Agrawal | Managing Director & Chief Financial Officer |
| Parul Agrawal | Non Executive Director |
Genomic Valley Biotech Similar Stocks
Genomic Valley Biotech FAQs
The Buying Price of Genomic Valley Biotech share is 31.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Genomic Valley Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Genomic Valley Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Genomic Valley Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Genomic Valley Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Genomic Valley Biotech’s valuation compare Sector P/E, P/B which are 30.24 & 1.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Genomic Valley Biotech is 9.71 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Genomic Valley Biotech share price is 46.46 & 20.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Genomic Valley Biotech belongs to the Agriculture sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
